Reducing AAV Immunogenicity Through Capsid Engineering
Time: 11:00 am
day: Conference Day One
Details:
- Analyzing the role of inverted terminal repeat regions in gene therapy immunogenicity
- Engineering ITRs to enhance AAV specificity and reduce dosage
- Modifying ITRs to evade immune recognition and increase the durability of expression
